Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Co-trimoxazole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par le sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication accidentelle par le sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication intentionnelle par le sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par le sulfaméthoxazole et triméthoprime d'intention indéterminée |
Causative agent (attribute) |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole + trimethoprim adverse reaction |
Causative agent (attribute) |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
allergie aux sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
surdose de sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
surdose accidentelle de sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
surdose intentionnelle de sulfaméthoxazole et triméthoprime |
Causative agent (attribute) |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
surdose de sulfaméthoxazole et triméthoprime d'intention indéterminée |
Causative agent (attribute) |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole [generic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 80mg/400mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 160mg/800mg dispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 120mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulfamethoxazole 80 mg/mL and trimethoprim 16 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 240mg/5mL pediatric suspension (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 480mg/5mL intravenous infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 40mg/200mg/5mL pediatric s/f suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole [proprietary] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral sulfamethoxazole+trimethoprim |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sulfamethoxazole and trimethoprim in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 96mg/mL infusion solution 20mL ampule (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 16mg/80mg/mL infusion solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-trimoxazole 960mg/10mL intravenous infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
cotrimoxazolo |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|